Search Within

Andrew D Zelenetz

  1. "1996"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. Hematologic Malignancies, Division of (7)
  4. Lymphoma (7)
  5. Adult Leukemia (2)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)

More Groups

People
  1. Ariela Noy (2)
  2. Mark Weiss (2)
  3. Peter Maslak (2)
  4. Stephen Nimer (2)
  5. Anthony Gucciardo (1)
  6. Craig Moskowitz (1)

More People

Years
  1. 1996 (7)
Publications
  1. Blood (3)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  3. Differentiation (1)
  4. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Society of Hematology (3)
  2. American Association for Cancer Research (2)
  3. International Society of Differentiation (1)
  4. National Academy of Sciences (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microsatellite instability, p53 mutation and Her2/neu amplification in a population of primary breast cancers
    Meeting Abstract

    Rush, E. B.; Abouezzi, Z.; Zelenetz, A. D.; Borgen, P. I.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Distinct apoptotic pathways in human multiple myeloma
    Meeting Abstract

    Zhang, X.; Siegel, D.; Pearse, R.; Zelenetz, A.; Michaeli, J.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
    Meeting Abstract

    Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma
    Meeting Abstract

    Moskowitz, C. H.; Glassman, J. R.; Wuest, D.; Reich, L.; Gucciardo, A.; Coady-Lyons, N.; Zelenetz, A. D.; Nimer, S. D.
    Blood (1996)

    Fulltext@MSK | Save
  • Clonotypic PCR confirms minimal residual disease (MRD) in CLL nodular PR: Preliminary results from a sequential treatment CLL protocol
    Meeting Abstract

    Noy, A.; Verma, R.; Rahman, Z. U.; Glenn, M.; Maslak, P.; Weiss, M.; Zelenetz, A. D.
    Blood (1996)

    Fulltext@MSK | Save
  • The AML1/ETO fusion protein activates transcription of BCL-2
    Journal Article

    Klampfer, L.; Zhang, J.; Zelenetz, A. O.; Uchida, H.; Nimer, S. D.
    Proceedings of the National Academy of Sciences of the United States of America (1996)

    Fulltext@MSK | Save
  • Derivation and characterization of retinoid-resistant human embryonal carcinoma cells
    Journal Article

    Moasser, M. M.; Khoo, K. S.; Maerz, W. J.; Zelenetz, A.; Dmitrovsky, E.
    Differentiation (1996)

    Fulltext@MSK | Save